Recurrent LRRK2 (park8) mutations in early-onset Parkinson's disease

Katja Hedrich, Susen Winkler, Johann Hagenah, Kemal Kabakci, Meike Kasten, Eberhard Schwinger, Jens Volkmann, Peter P. Pramstaller, Vladimir Kostic, Peter Vieregge, Christine Klein*

*Corresponding author for this work
39 Citations (Scopus)


Mutations in LRRK2 (leucine-rich repeat kinase 2) have been associated with autosomal dominant Parkinson's disease (PD) and cluster in several 3′ exons of the gene. The majority of mutations have been detected in late-onset cases (age at onset >50 years). We screened 5 of the 51 exons of LRRK2 that previously have been reported to harbor mutations in 98 early-onset and 42 late-onset PD patients. We identified two mutations (c.4321C>T, c.6055G>A) in three early-onset patients. Screening of an additional 220 early-onset PD patients for these mutations revealed another mutation carrier. In conclusion, LRRK2 mutations need to be considered also in early-onset PD.

Original languageEnglish
JournalMovement Disorders
Issue number9
Pages (from-to)1506-1510
Number of pages5
Publication statusPublished - 01.09.2006


Dive into the research topics of 'Recurrent LRRK2 (park8) mutations in early-onset Parkinson's disease'. Together they form a unique fingerprint.

Cite this